Status:
COMPLETED
A Comparison of Fellow Eyes Undergoing LASIK or PRK With a Wavefront-guided Excimer Laser Versus a Wavefront-optimized Excimer Laser
Lead Sponsor:
Edward E. Manche
Conditions:
Hyperopia
Myopia
Eligibility:
All Genders
21-60 years
Phase:
NA
Brief Summary
Subjects with myopia, hyperopia and astigmatism are being randomized to be treated in one eye with a wavefront-guided excimer laser and their fellow eye treated with a wavefront-optimized excimer lase...
Detailed Description
Subjects with myopia, hyperopia and astigmatism are being randomized by ocular dominance to be treated with either PRK or LASIK. One eye will be treated with a wavefront-guided excimer laser and the f...
Eligibility Criteria
Inclusion
- Healthy subjects age 21 and older.
- Subjects with nearsightedness, farsightedness and/or astigmatism.
Exclusion
- Autoimmune diseases.
- Children.
- Women pregnant or nursing.
- Ectatic corneal disease.
- Previous ocular surgery.
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 3 2022
Estimated Enrollment :
137 Patients enrolled
Trial Details
Trial ID
NCT01135719
Start Date
April 1 2009
End Date
December 3 2022
Last Update
December 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305